Clinical TrialsSearch results
Number of results: 2443
Other
- A Phase I Dose Intensification Study of three dimentional conformal thoracic radiotherapy with concurrent cisplatin and TS-1 for unresectable stage III non-small cell lung cancer
- non-small cell lung cancer
- Shizuoka Cancer Center, The Cancer Institute Hospital of JFCR
- 2008-12-02
Other
- A Phase I study of cabozantinib monotherapy in pediatric patients with recurrent and/or refractory solid tumors
- Refractory pediatric solid tumor
- Arakawa Ayumu
- 2022-02-15
Other
- A phase I study of cancer vaccine with NY-ESO-1 overlapping peptides in patients with advanced cancers expressing NY-ESO-1 antigen
- advanced esophageal cancer, stomach cancer, non-small cell lung cancer (NSCLC), malignant melanoma, bladder cancer.
- Department of Immunology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- 2009-04-10
Other
- A PHASE I STUDY OF PRALSETINIB IN PATIENTS WITH RET ALTERED SOLID TUMOR
- RET altered solid tumor
- Yanagitani Noriko
- 2021-06-11
Other
- A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil; OK-432 and Montanide; ISA-51 in patients with cancers expressing NY-ESO-1 antigen
- advanced esophageal cancer, stomach cancer, non-small cell lung cancer (NSCLC), malignant melanoma
- Department of Immunology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- 2008-07-24
Other
- A phase I study of vinorelbine concurrent with thoracic radiotherapy in elderly patients with l locally advanced non-small cell lung cancer(WJTOG 3005).
- Non-small cell lung cancer
- West Japan Oncology Group
- 2008-09-26
Other
- A phase I trial of unrelated bone marrow transplantation for adult T cell leukemia/lymphoma following reduced intensity conditioning regimen.
- Adult T cell leukemia/lymphoma
- Grant for anticancer project from Ministry of Health, Welfare, and Labor of Japan.
- 2008-09-08
Other
- A Phase I, Open-Label, Multicenter Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-A2009 for Injection in Patients With Advanced Solid Tumors
- Advanced Solid Tumors
- Shi Wei
- 2022-10-26
Other
- A Phase I, skin safety study with SKE-18 1% cream in healthy Japanese participants
- Rosacea
- Kasumi Sanpei
- 2024-02-08
Other
- A Phase I/Ib, Open-label, Multi-center Study of DFF332 as a Single Agent and in Combination With Everolimus or IO Agents in Patients With Advanced/Relapsed ccRCC and Other Malignancies With HIF2alpha Stabilizing Mutations
- Carcinoma, Renal Cell
- Yonemura Masataka
- 2021-08-13